Fecal Microbiota Transplant Beneficial in T1DM With Bowel Symptoms
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 13, 2025 -- For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical outcomes, according to a study published in the January issue of eClinicalMedicine.
Katrine Lundby Høyer, from Aarhus University in Denmark, and colleagues conducted a randomized, double-blind, placebo-controlled pilot trial involving adults with type 1 diabetes and moderate-to-severe gastrointestinal symptoms. Twenty patients were randomly assigned to receive 25 capsules of encapsulated FMT, containing 50 mg of feces, administered in a single dose, or placebo capsules containing glycerol, saline, and food coloring. All patients received a second intervention of FMT.
The researchers observed no difference between the groups in adverse events, with four patients in the FMT group reporting seven adverse events and five patients in the placebo group reporting 19. Diarrhea, bloating, and abdominal pain were the most frequent adverse events. The median Gastrointestinal Symptom Rating Scale-Irritable Bowel Syndrome score was reduced from 58 to 35 among patients who received FMT and from 64 to 56 among patients receiving placebo. There was improvement in the Irritable Bowel Syndrome Impact Scale score, from 108 to 140 with FMT and from 77 to 92 with placebo. There was a decline in the Patient Assessment of Gastrointestinal Symptom Severity Index from a median of 42 to 25 and from 47 to 41 after FMT and placebo, respectively.
"To our knowledge, this study represents the most promising clinical effect of FMT beyond its established efficacy in treating Clostridium difficile infection," the authors write.
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-14 06:00
Read more
- FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
- What's the Link Between Memory Problems and Sexism?
- Empagliflozin Not Tied to Risk for New Nonproliferative Diabetic Retinopathy
- U.S. FDA Approves Pfizer’s Braftovi Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
- Cold Weather Deaths Keep Rising for Americans
- Access to Green Space May Help Reduce Kids' Screen Time
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions